Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,248 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07545512Recruiting
Finding heart attack risk markers in moderate heart weakness
This study helps doctors identify which heart attack survivors with moderate heart weakness are at highest risk of sudden cardiac death. Researchers will collect health information and heart imaging over 5 years to find early warning signs.
AmiensAges 18–80 - NCT07543263Recruiting
AI-assisted ultrasound diagnosis for pancreatic cysts
This study uses artificial intelligence to help read endoscopic ultrasound images of pancreatic cysts. It aims to make diagnosis more accurate and could help guide treatment decisions.
Jinan, ShandongAges 18 years+ - NCT07549711Enrolling by invitation
Understanding Long Anterior Zonule Eye Condition and Genes
This research study examines a rare eye condition called long anterior zonule (LAZ) that affects the structures supporting the lens. Researchers will compare people with this condition to those without it, and study families where LAZ runs in the family, to understand how genes and physical eye changes relate to this condition.
Fuzhou, FujianAges 18 years+ - NCT07548762Recruiting
Skin-Sparing vs. Standard Mastectomy for Breast Cancer
This study compares two surgical approaches to remove breast cancer: one that preserves more of the skin (skin-sparing) versus a standard approach. The goal is to see which method results in fewer wound-healing problems after surgery.
Guangzhou, GuangdongAges 18–75 - NCT07544823Recruiting
Study of Early Markers for Osteoarthritis
This study looks for early signs of osteoarthritis (joint wear and tear) in your blood or other samples. Understanding these markers may help doctors detect and treat osteoarthritis sooner.
Xinxiang, HenanAges 40–70 - NCT07545616Recruiting
Finding biomarkers for femoral head bone death
This study looks for biological signs (biomarkers) that can help identify and understand osteonecrosis of the femoral head—a condition where bone in the hip dies. Researchers hope these signs will improve how doctors diagnose and treat the condition.
Xinxiang, HenanAges 18–70 - NCT07546383Recruiting
New Immunotherapy Combination for Advanced Head and Neck Cancer
This trial tests a new combination of two immunotherapy drugs (called iparomlimab and tuvonralimab), with or without chemotherapy, for head and neck squamous cell carcinoma that has returned or spread after previous treatment. The goal is to see if this combination can help people with this cancer live longer with fewer side effects.
Haikou, HainanAges 18–75 - NCT07543614Recruiting
Frame Running for Kids and Teens With Movement Challenges
This study looks at whether Frame Running—a special bike activity—helps children and teens with cerebral palsy or other movement disabilities stay active and involved in their communities. Researchers want to see if regular Frame Running training improves participation and exercise for young people.
Odense, Region SyddanmarkAges 8–18 - NCT07549880Recruiting
Ultrasound to detect infections after abdominal surgery
This study tests whether bedside ultrasound—a simple imaging tool used at your hospital bed—can help doctors spot surgical infections early after abdominal surgery. Catching infections sooner might help you recover faster and avoid serious complications.
Herlev, Capital RegionAges 18 years+ - NCT07550114Recruiting
Nerve blocks to reduce bleeding and pain after spine surgery
This study compares two types of nerve blocks (numbing injections) given during lumbar spine fusion surgery to see which better reduces bleeding and pain after the operation. If you're having spine surgery, this trial might help your recovery be smoother with less pain and bleeding.
Barcelona, BarcelonaAges 18 years+ - NCT07550010Recruiting
Digital Screening for Cervical Cancer in Cameroon
This study tests a new digital imaging method to help screen women for cervical cancer risk in Cameroon. It may help catch cervical problems earlier using easier-to-read pictures of the cervix.
YaoundéAges 25–50 - NCT07543666Recruiting
Exercise and inflammation markers in healthy young adults
This study looks at how starting a structured exercise program affects inflammation in the body. Researchers want to understand the link between physical activity and inflammation markers in healthy young adults.
München, BavariaAges 18–45 - NCT07548697RecruitingEarly Phase 1
Safety study of CT1182 for relapsed B-cell lymphoma
This early-stage trial tests a new drug called CT1182 for B-cell non-Hodgkin lymphoma that has come back or stopped responding to prior treatment. The study will measure how safe the drug is, how well it works, and how your body processes it.
Wuhan, HubeiAges 18–75 - NCT07542951Enrolling by invitationPhase 4
TAF vs TDF antiviral treatment during pregnancy for hepatitis B
This study compares two antiviral medications (TAF and TDF) in pregnant women with hepatitis B to see which is safer and more effective during pregnancy and for the baby's health.
Guangzhou, GuangdongAges 20–40 - NCT07547098Recruiting
Heart, Kidney, and Metabolism Health Long-Term Study
This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.
Fuzhou, FujianAges 18–80 - NCT07547254Enrolling by invitation
Palmitoleic Acid Oil for Preventing Pressure Sores
This trial tests whether a special oil applied to the skin can prevent pressure injuries (bedsores) in patients at high risk. You would be screened using a skin moisture sensor to confirm your risk level.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07551375Recruiting
Fast MRI scan to diagnose gallbladder inflammation
This study tests whether a new type of quick MRI scan can reliably detect acute cholecystitis—sudden inflammation of the gallbladder. If it works well, doctors may be able to diagnose this condition faster and help patients get treatment sooner.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07544771Recruiting
HeartLogic monitoring in heart failure patients
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
AmiensAges 18 years+ - NCT07551037RecruitingPhase 1
Immune Therapy to Prevent AML Relapse After Chemotherapy
This trial tests a new type of maintenance therapy for acute myeloid leukemia (AML) patients who have already responded well to chemotherapy. The treatment uses your own immune cells to help prevent the cancer from coming back.
Fuzhou, FujianAges 18–70 - NCT07549399RecruitingPhase 3
Radiation, Chemotherapy, and Immunotherapy for Rectal Cancer
This trial tests a combination of radiation, chemotherapy, and immunotherapy drugs before surgery for people with locally advanced rectal cancer. The goal is to shrink the tumor and improve outcomes for patients with higher-risk disease.
Guangzhou, GuangdongAges 18–75 - NCT07550972Enrolling by invitationPhase 2
Combination drug treatment before surgery for advanced head and neck cancer
This study tests two drugs (pertuzumab and lenvatinib) given together before surgery for advanced head and neck squamous cell carcinoma. The goal is to shrink the tumor and improve outcomes for patients who haven't received prior cancer treatment.
Hangzhou, ZhejiangAges 18–75 - NCT07550296RecruitingPhase 2
Second IV Clot-Dissolving Treatment for Major Stroke
This trial tests giving a second dose of an IV clot-dissolving medicine (prourokinase) to patients who had a stroke from a large clot but didn't improve enough after the first dose. The goal is to see if a second dose within 6 hours of stroke onset can help more patients recover.
Shenyang, None SelectedAges 18–80 - NCT07549841RecruitingPhase 2
Heart imaging study for transthyretin amyloidosis
This study tests a new type of heart imaging scan called [68Ga]Ga-FAPI-46 PET to help doctors see and track transthyretin cardiac amyloidosis (a disease where abnormal proteins damage the heart). The scan may help identify which patients are getting worse.
NantesAges 18 years+ - NCT07542938Recruiting
Drug-coated balloon for narrowed brain arteries
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
Beijing, Beijing MunicipalityAges 18–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,248 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.